Literature DB >> 19390782

Strong inhibition of replicative DNA synthesis in the developing rat cerebral cortex and glioma cells by roscovitine.

Juan Sebastian Yakisich1, Marina Fernanda Vita, Ake Siden, Deborah Ruth Tasat, Mabel Cruz.   

Abstract

The effects of the cyclin-dependent kinase inhibitors roscovitine and olomoucine on DNA synthesis rate during normal rat brain development were studied by using short time (90 min) incubation. Both purine analogues at 100 microM concentration decreased the DNA synthesis of rat cerebral cortex in an age-dependent manner. The maximum inhibitory effect (approximately 90% for roscovitine, approximately 60% for olomoucine) occurred in rats of 2-13 days postnatal age. In adult rats (> 60 days postnatal age), the effect of both purine analogues was low. Roscovitine even at 200 microM concentration did not inhibit the fraction of DNA synthesis insensitive to hydroxyurea (unscheduled DNA synthesis (UDS)). In addition, in the RG2 rat glioma model, roscovitine produced a strong inhibition of DNA synthesis in glioma cells when compared to adult normal tissue. Since in adult rat brain more than 60% of DNA synthesis is related to DNA repair, usually measured as UDS, our results indicate that roscovitine strongly blocks ongoing DNA synthesis connected with replicative processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19390782     DOI: 10.1007/s10637-009-9254-4

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  46 in total

1.  Chemical inhibitors of cyclin-dependent kinases.

Authors:  L Meijer
Journal:  Trends Cell Biol       Date:  1996-10       Impact factor: 20.808

2.  Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

Authors:  A McShea; P L Harris; K R Webster; A F Wahl; M A Smith
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  Repair replication, unscheduled DNA synthesis, and the repair of mammalian DNA.

Authors:  R B Painter; J E Cleaver
Journal:  Radiat Res       Date:  1969-03       Impact factor: 2.841

4.  Inhibition of DNA synthesis in human gliomas by roscovitine.

Authors:  J S Yakisich; J Boethius; I O Lindblom; L Wallstedt; V I Vargas; A Sidén; M H Cruz
Journal:  Neuroreport       Date:  1999-08-20       Impact factor: 1.837

5.  DNA turnover in rat cerebral cortex.

Authors:  C Perrone-Capano; G D'Onofrio; A Giuditta
Journal:  J Neurochem       Date:  1982-01       Impact factor: 5.372

Review 6.  Recent progress in the discovery and development of cyclin-dependent kinase inhibitors.

Authors:  Peter M Fischer; Athos Gianella-Borradori
Journal:  Expert Opin Investig Drugs       Date:  2005-04       Impact factor: 6.206

7.  Cyclin and cyclin-dependent kinase expression in human astrocytoma cell lines.

Authors:  P B Dirks; S L Hubbard; M Murakami; J T Rutka
Journal:  J Neuropathol Exp Neurol       Date:  1997-03       Impact factor: 3.685

8.  Deletions and rearrangements inactivate the p16INK4 gene in human glioma cells.

Authors:  K S Srivenugopal; F Ali-Osman
Journal:  Oncogene       Date:  1996-05-02       Impact factor: 9.867

9.  Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.

Authors:  Y Ono; T Tamiya; T Ichikawa; K Kunishio; K Matsumoto; T Furuta; T Ohmoto; K Ueki; D N Louis
Journal:  J Neuropathol Exp Neurol       Date:  1996-10       Impact factor: 3.685

10.  Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.

Authors:  J J Pei; I Grundke-Iqbal; K Iqbal; N Bogdanovic; B Winblad; R F Cowburn
Journal:  Brain Res       Date:  1998-06-29       Impact factor: 3.252

View more
  5 in total

Review 1.  Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.

Authors:  Bernardo Sousa-Pinto; Manuel J Ferreira-Pinto; Mário Santos; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

Review 2.  Roscovitine in cancer and other diseases.

Authors:  Jonas Cicenas; Karthik Kalyan; Aleksandras Sorokinas; Edvinas Stankunas; Josh Levy; Ingrida Meskinyte; Vaidotas Stankevicius; Algirdas Kaupinis; Mindaugas Valius
Journal:  Ann Transl Med       Date:  2015-06

3.  Pankiller effect of prolonged exposure to menadione on glioma cells: potentiation by vitamin C.

Authors:  Marina F Vita; Nivedita Nagachar; Dimitrios Avramidis; Zahid M Delwar; Mabel H Cruz; Åke Siden; Kajsa M Paulsson; Juan Sebastian Yakisich
Journal:  Invest New Drugs       Date:  2010-07-13       Impact factor: 3.850

4.  Peptide-Functionalized Nanoparticles-Encapsulated Cyclin-Dependent Kinases Inhibitor Seliciclib in Transferrin Receptor Overexpressed Cancer Cells.

Authors:  Guan Zhen He; Wen Jen Lin
Journal:  Nanomaterials (Basel)       Date:  2021-03-18       Impact factor: 5.076

Review 5.  Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action.

Authors:  Paweł Łukasik; Irena Baranowska-Bosiacka; Katarzyna Kulczycka; Izabela Gutowska
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.